MERCK & CO., INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 115.25 USD | +0.47% |
|
-2.82% | +5.71% |
| 12/09 | Merck Says Health Canada Approved Keytruda as Treatment for Hard-to-Treat Solid Tumors | MT |
| 11/09 | Merck: positive results for HPV vaccine | CF |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceutical | 4.18TCr | 4.3TCr | 4.28TCr | 5.2TCr | 5.36TCr | |||||
D&A | 14Cr | 69Cr | 60L | 50L | 50L | |||||
Operating Income | 2.83TCr | 2.97TCr | 3.1TCr | 3.69TCr | 3.89TCr | |||||
Veterinary Drugs | ||||||||||
Animal Health | 439.3Cr | 470.3Cr | 556.8Cr | 555Cr | 562.5Cr | |||||
D&A | 11Cr | 16Cr | 16Cr | 18Cr | 20Cr | |||||
Operating Income | 160.9Cr | 165Cr | 195Cr | 196.3Cr | 173.7Cr | |||||
Unallocated Other Revenues | 52Cr | 25Cr | 38Cr | 172.8Cr | 91Cr | |||||
Operating Income | 36Cr | 14Cr | 16Cr | 116Cr | -357.2Cr | |||||
D&A | 1Cr | 10L | - | - | - | |||||
Operating Income | -949.9Cr | -1.31TCr | -1.17TCr | -1.3TCr | - | |||||
Operating Income | -157.3Cr | -160.2Cr | - | - | -162.5Cr | |||||
Operating Income | - | - | -163.6Cr | -208.5Cr | -204.4Cr | |||||
Operating Income | - | - | -141.4Cr | -164.2Cr | - | |||||
Pharmaceutical Contract Manufacturing Services | ||||||||||
Other profits | 18Cr | 2.3Cr | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | -70L | 10L | - | - | 47Cr |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 2.03TCr | 2.1TCr | 2.24TCr | 2.72TCr | 2.85TCr | |||||
Total Assets | 897.4Cr | 1.05TCr | 1.18TCr | 1.29TCr | 1.39TCr | |||||
Europe, Middle East and Africa | 1.27TCr | 1.36TCr | 1.33TCr | 1.45TCr | 1.33TCr | |||||
Total Assets | 476.7Cr | 605.9Cr | 608.1Cr | 699.3Cr | 756.2Cr | |||||
China | 320.7Cr | 362.4Cr | 437.8Cr | 519.1Cr | 680.2Cr | |||||
Total Assets | 17Cr | 22Cr | 22Cr | 21Cr | 19Cr | |||||
Asia Pacific (other than China and Japan) | 294.3Cr | 286.4Cr | 240.7Cr | 361.4Cr | 322.5Cr | |||||
Total Assets | 71Cr | 76Cr | 86Cr | 97Cr | 102.2Cr | |||||
Japan | 358.3Cr | 337.6Cr | 272.6Cr | 362.9Cr | 316.4Cr | |||||
Total Assets | 15Cr | 17Cr | 16Cr | 14Cr | 13Cr | |||||
Latin America | 246.9Cr | 227.4Cr | 220.6Cr | 258.2Cr | 308.6Cr | |||||
Total Assets | 27Cr | 25Cr | 20Cr | 22Cr | 22Cr | |||||
Other | 160.6Cr | 122.9Cr | 122.1Cr | 256.8Cr | 210.4Cr | |||||
Total Assets | 60L | 50L | 40L | 50L | 40L | |||||
Asia Pacific | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - |
- Stock Market
- Equities
- MRK Stock
- Financials Merck & Co., Inc.
- Business Segments
MarketScreener is also available in this country: United States.
Switch edition